Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/29/2025

Best Medications for Psychosis

Initial Medication Selection

  • Atypical antipsychotics are preferred over typical antipsychotics due to better tolerability and fewer extrapyramidal side effects, even though both may be equally efficacious in reducing positive psychotic symptoms 1, 4
  • The British Journal of Psychiatry recommends initial target doses for first-episode psychosis of risperidone 2 mg/day or olanzapine 7.5-10.0 mg/day 1, 2
  • Low doses should be used initially, with careful titration to minimize side effects, as recommended by the British Journal of Psychiatry 1, 5
  • Extrapyramidal side effects should be avoided to encourage future medication adherence, according to the British Journal of Psychiatry 1

Dosing Considerations

  • The British Journal of Psychiatry suggests that after initial titration, antipsychotic doses should only be increased at widely spaced intervals (usually 14-21 days) if response has been inadequate 1
  • Maximum recommended doses for first-episode psychosis are risperidone 4 mg/day, olanzapine 20 mg/day, and haloperidol 4-6 mg/day (if typical antipsychotics are used), as recommended by the British Journal of Psychiatry 1, 2, 5
  • Dose increases should stay within the limits of sedation and extrapyramidal side effects, according to the British Journal of Psychiatry 1

Treatment Algorithm

  • The British Journal of Psychiatry recommends starting with an atypical antipsychotic (risperidone 2 mg/day or olanzapine 7.5-10 mg/day) as first-line treatment 1, 2, 6
  • If positive psychotic symptoms persist after an adequate trial (4-6 weeks), consider switching to another atypical antipsychotic, as suggested by the Journal of the American Academy of Child and Adolescent Psychiatry 1, 7
  • For treatment-resistant psychosis, clozapine may be considered, though it requires close monitoring due to risk of agranulocytosis, according to the Journal of the American Academy of Child and Adolescent Psychiatry 7

Monitoring and Follow-up

  • The British Journal of Psychiatry recommends monitoring for common side effects including extrapyramidal symptoms and sedation 1
  • Maintain continuity of care with the same treating clinicians for at least the first 18 months of treatment, as recommended by the British Journal of Psychiatry 4
  • Include families in the treatment plan and provide them with emotional support and practical advice, according to the British Journal of Psychiatry 1, 4
  • Develop supportive crisis plans to facilitate recovery and treatment acceptance, as suggested by the British Journal of Psychiatry 1

Common Pitfalls to Avoid

  • Using excessive doses in first-episode psychosis increases side effects without improving efficacy, according to the British Journal of Psychiatry 1
  • Failing to rule out secondary causes of psychosis before initiating psychiatric treatment is a common pitfall, as noted by Praxis Medical Insights 6
  • Neglecting psychosocial interventions is a common mistake, as they are essential components of comprehensive treatment, according to the British Journal of Psychiatry 1, 4
  • Changing medications too quickly before an adequate trial period (4-6 weeks) is not recommended, as suggested by the Journal of the American Academy of Child and Adolescent Psychiatry 7
  • Overlooking the importance of family involvement in the treatment process is a common pitfall, according to the British Journal of Psychiatry 1, 4